Nikos Pagratis
Gilead Sciences (United States)(US)
Publications by Year
Research Areas
HIV/AIDS drug development and treatment, Hepatitis C virus research, HIV Research and Treatment, Hepatitis B Virus Studies, Bacteriophages and microbial interactions
Most-Cited Works
- → Clinical targeting of HIV capsid protein with a long-acting small molecule(2020)403 cited
- → Potent 2′-amino-, and 2′-fluoro-2′- deoxyribonucleotide RNA inhibitors of keratinocyte growth factor(1997)214 cited
- → In Vitro Antiviral Activity and Resistance Profile Characterization of the Hepatitis C Virus NS5A Inhibitor Ledipasvir(2016)69 cited
- → The novel CaMKII inhibitor GS-680 reduces diastolic SR Ca leak and prevents CaMKII-dependent pro-arrhythmic activity(2018)57 cited
- → Identification of Orally Available Naphthyridine Protein Kinase D Inhibitors(2010)53 cited
- → High-Throughput Kinetic Screening of Hybridomas to Identify High-Affinity Antibodies Using Bio-Layer Interferometry(2014)50 cited
- → Novel Hepatitis C Virus Reporter Replicon Cell Lines Enable Efficient Antiviral Screening against Genotype 1a(2010)50 cited
- → Rapid preparation of single stranded DNA from PCR products by streptavidin induced electrophoretic mobility shift(1996)49 cited
- → Affinities between the Binding Partners of the HIV-1 Integrase Dimer-Lens Epithelium-derived Growth Factor (IN Dimer-LEDGF) Complex(2009)45 cited
- → Identification of Potent and Selective Amidobipyridyl Inhibitors of Protein Kinase D(2010)41 cited